SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents
暂无分享,去创建一个
E. Boerwinkle | S. Kelder | S. DeSantis | H. W. Kohl | Leqing Wu | D. Lakey | J. Shuford | Michael O. Gonzalez | S. Pont | A. Yaseen | J. Ross | Yashar Talebi | M. Valerio-Shewmaker | M. Swartz | Sarah E. Messiah | Rhiana A. Abbas | Lindsay N. Padilla
[1] C. Murray,et al. Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021 , 2022, Archives of Disease in Childhood.
[2] William F. Fadel,et al. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[3] H. Bregman,et al. Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[4] Andrew L. Phillips,et al. Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[5] William F. Fadel,et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[6] G. Chodick,et al. Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting , 2022, European Journal of Pediatrics.
[7] Theresa M Sokol,et al. COVID-19 Outbreaks at Youth Summer Camps — Louisiana, June–July 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[8] C. Steves,et al. Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta Variant , 2021, medRxiv.
[9] Jonathan E. Schmitz,et al. The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study , 2021, BMC Pediatrics.
[10] S. McLafferty,et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[11] Joshua B. Singer,et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study , 2021, The Lancet Infectious Diseases.
[12] S. Maurer-Stroh,et al. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Andrew E. Williams,et al. Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience , 2021, Pediatrics.
[14] Manish M Patel,et al. Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[15] D. Fremont,et al. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA , 2021, mSphere.
[16] J. Tate,et al. Symptoms and Transmission of SARS-CoV-2 Among Children — Utah and Wisconsin, March–May 2020 , 2020, Pediatrics.
[17] G. Kochs,et al. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany , 2020, JAMA pediatrics.
[18] A. Šedivá,et al. Searching for COVID-19 Antibodies in Czech Children—A Needle in the Haystack , 2020, Frontiers in Pediatrics.
[19] R. Viner,et al. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents , 2020, Archives of Disease in Childhood.
[20] R. Viner,et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. , 2020, JAMA pediatrics.
[21] Georgia Salanti,et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis , 2020, medRxiv.
[22] Jane A Dickerson,et al. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak , 2020, Nature Communications.
[23] M. Hernán,et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.
[24] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[25] Y. Tie,et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[26] A. Rowley. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children , 2020, Nature Reviews Immunology.
[27] A. Flahault,et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.
[28] A. Huppert,et al. The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children , 2020, medRxiv.
[29] C. Brasher,et al. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies , 2020, British Journal of Anaesthesia.
[30] J. Ludvigsson. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.
[31] G. Wong,et al. SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.
[32] Paul A. Harris,et al. The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.
[33] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[34] Shumei S. Guo,et al. 2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.